Equities

Synlogic Inc

Synlogic Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)1.43
  • Today's Change0.025 / 1.78%
  • Shares traded7.51k
  • 1 Year change-31.58%
  • Beta0.8400
Data delayed at least 15 minutes, as of Nov 22 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments4878129
Total Receivables, Net------
Total Inventory------
Prepaid expenses2.021.984.41
Other current assets, total0.150.180.31
Total current assets5080133
Property, plant & equipment, net182223
Goodwill, net------
Intangibles, net------
Long term investments--08.04
Note receivable - long term------
Other long term assets0.020.010.00
Total assets76111175
LIABILITIES
Accounts payable1.461.791.94
Accrued expenses7.789.447.59
Notes payable/short-term debt000
Current portion long-term debt/capital leases0.000.010.01
Other current liabilities, total110.880.53
Total current liabilities201210
Total long term debt00.000.02
Total debt0.000.020.03
Deferred income tax------
Minority interest------
Other liabilities, total121617
Total liabilities332827
SHAREHOLDERS EQUITY
Common stock0.010.070.07
Additional paid-in capital459442438
Retained earnings (accumulated deficit)(414)(357)(291)
Treasury stock - common(2.52)(2.52)--
Unrealized gain (loss)------
Other equity, total0.01(0.16)(0.05)
Total equity4383147
Total liabilities & shareholders' equity76111175
Total common shares outstanding9.194.454.65
Treasury shares - common primary issue0.280.280
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.